Borja Ibañez
CNIC · Centro Nacional de Investigaciones Cardiovasculares (CNIC, Madrid, Spain) · Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Borja Ibañez as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05223413 · REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEsFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III · recruiting · Anthracycline-induced Cardiac Toxicity, Lymphoma · principal investigator
- Ph4NCT04696185 · Dapagliflozin After Transcatheter Aortic Valve ImplantationSpanish Society of Cardiology · completed · Aortic Stenosis, Transcatether Aortic Valve Implantation · study director
- Ph4NCT03596385 · TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III · completed · Myocardial Infarction · principal investigator
- N/ANCT02561065 · Long-term Impact Evaluation of a Worksite-based Lifestyle Intervention to Reduce Cardiovascular Risk in Office WorkersFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III · completed · Atherosclerosis · principal investigator
- N/ANCT01410318 · Progression of Early Subclinical AtherosclerosisFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III · active not recruiting · Atherosclerosis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:45 UTC. The ranking covers the 200 most relevant of 47 PubMed records, and a shared surname and initials can bring in a namesake. All 47 on PubMed
- 320 citationsRCR 9.7
- 283 citationsRCR 13.0
- Polypill Strategy in Secondary Cardiovascular Prevention.N Engl J Med · 2022247 citationsRCR 18.6
- Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.J Am Coll Cardiol · 2016155 citationsRCR 5.7
- 151 citationsRCR 4.7
- 116 citationsRCR 31.6
- Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.N Engl J Med · 2025113 citationsRCR 29.9
- Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.J Am Coll Cardiol · 201684 citationsRCR 3.0
- Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.J Am Coll Cardiol · 201883 citationsRCR 3.8
- Bone marrow activation in response to metabolic syndrome and early atherosclerosis.Eur Heart J · 202262 citationsRCR 4.1